Methacrylic Acid

Methacrylic Acid

SCHEMBL907223

C=C(C)C(=O)O.CC(C)(N)CP(=O)(O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.42
FDPS P14324 1/20 0.34
TDP1 Q9NUW8 2/20 0.32
TET2 Q6N021 1/20 0.31
LAP3 P28838 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
PEPD P12955 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
BLM P54132 1/20 0.30
KMT2A Q03164 1/20 0.30
PGK1 P00558 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL970448 0.82
Acrylic Acid SCHEMBL907450 0.80 GRM4 (0.42) GRM4FDPSTDP1LAP3GRIN2D
Methacrylic Acid SCHEMBL11265929 0.76 TDP1 (0.39) GRM4TDP1TET2MEN1LMNA
Methacrylic Acid SCHEMBL4928189 0.76 TDP1 (0.39) GRM4TDP1TET2MEN1KMT2A
SCHEMBL28609591 0.75 GRM4 (0.35) GRM4PGK1PGK2
Methacrylic Acid SCHEMBL14631234 0.75 TDP1 (0.47) FDPSTDP1TET2LMNATSHR
Medronic Acid SCHEMBL9658866 0.73 KDM4E (0.53) TDP1LAP3GRIN2DGRIN3BGRIN1
Methacrylic Acid SCHEMBL5477359 0.73 LAP3 (0.39) FDPSTDP1LAP3GRIN2DGRIN3B
Methacrylic Acid SCHEMBL16668705 0.72 PEPD (0.43) TDP1PEPDMEN1LMNAHPGD
Methacrylic Acid SCHEMBL7649955 0.72 PEPD (0.43) TDP1PEPDMEN1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2277496-B1 Dental material containing surface-modified fillers IVOCLAR VIVADENT AG (LI) 2016-03-30 EP disclosed
US-8367748-B2 Surface-modified fillers IVOCLAR VIVADENT AG (LI) 2013-02-05 US disclosed
EP-2277496-A1 Dental material containing surface-modified fillers Ivoclar Vivadent AG (LI) 2011-01-26 EP disclosed
EP-1716836-B1 Surface-modified fillers IVOCLAR VIVADENT AG (LI) 2011-01-19 EP disclosed
EP-1716836-A1 Surface-modified fillers Ivoclar Vivadent AG (LI) 2006-11-02 EP disclosed
US-20060247329-A1 Surface-modified fillers IVOCLAR VIVADENT AG (LI) 2006-11-02 US disclosed
EP-1148071-B1 Hydrolysis-stable and polymerisable acrylphosphonic acid mono esters IVOCLAR VIVADENT AG (LI) 2004-06-16 EP disclosed
US-6710149-B2 USE OF ACRYLOPHOSPHONIC ACID AS A COMPONENT OF AN ADHESIVE, OF A POLYMER, OF A COMPOSITE, OF A CEMENT, OF A MOLDED ARTICLE AND IN PARTICULAR OF A DENTAL MATERIAL IVOCLAR VIVADENT AG (LI) 2004-03-23 US disclosed
EP-1148060-B1 Hydrolysis-stable and polymerisable acrylphosphonic acids IVOCLAR VIVADENT AG (LI) 2003-09-10 EP disclosed
EP-0909761-B1 Hydrolysis-stable and polymerizable acryl phosphonic acids IVOCLAR VIVADENT AG (LI) 2003-04-02 EP disclosed
US-6350839-B2 THE MONOESTER OF THE PHOSPHONIC ACID GROUP ALSO HAS IMPROVED SOLUBILITY IN POLAR ORGANIC SOLVENTS, AND WATER THAN THE CORRESPONDING ACID; USE IN DENTISTRY IVOCLAR VIVADENT AG (LI) 2002-02-26 US disclosed
US-20020016384-A1 Hydrolysis-stable and polymerizable acrylophosphonic acid IVOCLAR VIVADENT AG. 2002-02-07 US disclosed
US-20010044513-A1 Hydrolysis-stable and polymerizable acrylophosphonic acid monoesters IVOCLAR VIVADENT AG 2001-11-22 US disclosed
EP-1148071-A2 Hydrolysis-stable and polymerisable acrylphosphonic acid mono esters Ivoclar Vivadent AG (LI) 2001-10-24 EP disclosed
EP-1148060-A1 Hydrolysis-stable and polymerisable acrylphosphonic acids Ivoclar Vivadent AG (LI) 2001-10-24 EP disclosed
US-6172131-B1 MADE BY REACTING AN ALPHA-HALOMETHACRYLIC ACID ESTER WITH PROTECTED MONO- OR DIFUNCTIONAL PHOSPHONIC ACID ESTERS; USE AS COMPONENT OF DENTAL ADHESIVES DUE TO THEIR ADHESION-PROMOTING PROPERTIES IVOCLAR AG 2001-01-09 US disclosed
EP-0909761-A1 Hydrolysis-stable and polymerizable acryl phosphonic acids IVOCLAR AG (LI) 1999-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247329-A1 Surface-modified fillers MSR1, HRH4, OR10J3 GRM4 128/4885FDPS 4012/4885TDP1 4617/4885
US-20020016384-A1 Hydrolysis-stable and polymerizable acrylophosphonic acid PHOSPHO1, PPA1, ABHD16A GRM4 1827/4885FDPS 666/4885TDP1 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.